Pursuant to Regulation 30 read with sub para 15, Para A Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Senior ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchange that its senior management team will participate in an analyst/investor meeting with Nuvama Wealth and Investment Limited on Wednesday, 27th August 2025, starting at 3:30 p.m. The meeting will be held as a webinar. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the session. The schedule remains subject to change due to unforeseen circumstances on either side. The intimation has been signed by Managing Director Fredun Medhora.
This is a routine regulatory disclosure about an upcoming investor engagement. Since no UPSI will be shared, the meeting is unlikely to have a direct material impact on the stock price, though it may serve as a platform for the company to communicate its general business outlook to investors.